Trishula announces results from trial of gastric cancer combo therapy
13 Apr 2022 //
CLINICALTRIALSARENA
Trishula Tx Announces Oral Presentation on TTX-030 Anti-CD39 Antibody at AACR
04 Apr 2022 //
PRNEWSWIRE
Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer
21 Jan 2021 //
GLOBENEWSWIRE